CompletedNot Applicable

Effectiveness of Ophthalmic Antiseptic Preparations

Italy70 participantsStarted 2022-11-09

Plain-language summary

The aim of this clinical trial is to evaluate the effectiveness of two topical antiseptics, povidone-iodine (PVI) and chlorhexidine (CHX), in reducing conjunctival bacterial flora.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients undergoing cataract surgery * 18 years of age or older Exclusion Criteria: * Reported allergy or hypersensitivity to iodine or chlorhexidine * Active ocular infection * Contraindication to surgery * Pregnant women * Patients residing in nursing homes or prison * Patients who used antibiotic, antiviral or antifungal eye drops in the week preceding the intervention

What they're measuring

Conjunctival composition

Timeframe: 3 days. Conjunctival swabs were taken at baseline and after 3 days of treatment.

Trial details

NCT IDNCT05974124

SponsorAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-02-03

View on ClinicalTrials.gov More Antiseptics trials